SEQUENT SCIENTIFIC
Back to Balance Sheet
|
SEQUENT SCIENTIFIC Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹4.49 Cr | ₹4.33 Cr | ₹0.96 Cr | ₹1.67 Cr | ₹2.27 Cr |
What is the latest Contingent Liabilities ratio of SEQUENT SCIENTIFIC ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹4.49 Cr |
| Mar2024 | ₹4.33 Cr |
| Mar2023 | ₹0.96 Cr |
| Mar2022 | ₹1.67 Cr |
| Mar2021 | ₹2.27 Cr |
How is Contingent Liabilities of SEQUENT SCIENTIFIC Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.49 Cr | 3.79 | |
| Mar2024 | ₹4.33 Cr | 349.22 | |
| Mar2023 | ₹0.96 Cr | -42.20 | |
| Mar2022 | ₹1.67 Cr | -26.48 | |
| Mar2021 | ₹2.27 Cr | - | |
Compare Contingent Liabilities of peers of SEQUENT SCIENTIFIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SEQUENT SCIENTIFIC | ₹9,806.2 Cr | -0.4% | 6.8% | 36.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,075.0 Cr | 0.4% | 10.8% | 10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,486.0 Cr | 0.7% | 9.5% | 16.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,124.0 Cr | -2.5% | 6% | 36.2% | Stock Analytics | |
| CIPLA | ₹115,641.0 Cr | 9.7% | 16.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,589.0 Cr | 4.5% | 9.7% | 9% | Stock Analytics | |
SEQUENT SCIENTIFIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SEQUENT SCIENTIFIC | -0.4% |
6.8% |
36.7% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses